. Author manuscript; available in PMC: 2017 Jan 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):94–101. doi: 10.1097/QAI.0000000000000816

Table 4.

Associations between frequent CAI (> 1 time/week) and preferences for PrEP dosing

PrEP dosing	Bivariate Models		Multivariable Models¹
	OR (95% CI)	P	aOR (95% CI)	P
Daily PrEP	1.39 (1.08 to 1.79)	0.01	1.49 (1.13 to 1.91)	0.004
Event-driven PrEP²	0.71 (0.54 to 0.94)	0.02	0.76 (0.57 to 1.02)	0.065
Time-driven PrEP³	0.94 (0.73 to 1.22)	0.65	0.98 (0.75 to 1.27)	0.87

Adjusted for age, education (college grad or above versus less than), income, sexual orientation, in a monogamous relationship, depression, problematic alcohol use, having visited a provider in the past 12 months, and nation of residence (United States or Canada);

Defined as having to take a pill right before sex and soon after for it to work;

Defined as having to take a pill every Monday and Friday plus another pill soon after sex for it to work